XPhyto

Summary A Canadian life sciences start-up is disrupting COVID-19 testing in Europe with a breakthrough PCR diagnostics innovation XPhyto Therapeutics is bridging the technological gap between low-tech antigen testing (which has limited accuracy) and centralized PCR testing (the gold standard)  COVID-ID Lab happily combines the accuracy of PCR testing with the speed of disposable screening tests …

The post Mission Critical: How XPhyto Therapeutics Could Revolutionize PCR Testing appeared first on BTV News.